{"created":"2023-06-19T08:42:22.531019+00:00","id":10009,"links":{},"metadata":{"_buckets":{"deposit":"75f35340-32c2-4deb-870c-f6caf65a069f"},"_deposit":{"created_by":2,"id":"10009","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"10009"},"status":"published"},"_oai":{"id":"oai:gunma-u.repo.nii.ac.jp:00010009","sets":["719:759"]},"author_link":["41093","41095","41094"],"item_2_alternative_title_18":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"レンバチニブの治療をうけた肝細胞癌患者における奏効率、無増悪生存期間、有害事象の解析"}]},"item_2_date_granted_63":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2022-06-30"}]},"item_2_degree_grantor_61":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"群馬大学"}]}]},"item_2_degree_name_60":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_2_description_39":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Thesis or Dissertation","subitem_description_type":"Other"}]},"item_2_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"学位記番号：医博乙1413","subitem_description_type":"Other"}]},"item_2_dissertation_number_64":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"12301乙第1413号"}]},"item_2_full_name_2":{"attribute_name":"著者(ヨミ)","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"41094","nameIdentifierScheme":"WEKO"}],"names":[{"name":"ハタナカ, タケシ"}]}]},"item_2_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"41095","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Hatanaka, Takeshi"}]}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"畑中, 健"}],"nameIdentifiers":[{"nameIdentifier":"41093","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-04-14"}],"displaytype":"detail","filename":"m-o1413-1.pdf","filesize":[{"value":"102.8 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"論文要旨","url":"https://gunma-u.repo.nii.ac.jp/record/10009/files/m-o1413-1.pdf"},"version_id":"0447af4f-429c-4846-ba75-8fa69a8baf08"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-04-14"}],"displaytype":"detail","filename":"m-o1413-2.pdf","filesize":[{"value":"99.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"審査要旨","url":"https://gunma-u.repo.nii.ac.jp/record/10009/files/m-o1413-2.pdf"},"version_id":"84c5e00c-a4c2-4ca2-be28-94690d53c9df"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"adverse events","subitem_subject_scheme":"Other"},{"subitem_subject":"albumin-bilirubin grade","subitem_subject_scheme":"Other"},{"subitem_subject":"tepatocellular carcinoma","subitem_subject_scheme":"Other"},{"subitem_subject":"lenvatinib","subitem_subject_scheme":"Other"},{"subitem_subject":"objective response","subitem_subject_scheme":"Other"},{"subitem_subject":"progression-free-survival","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study"}]},"item_type_id":"2","owner":"2","path":["759"],"pubdate":{"attribute_name":"公開日","attribute_value":"2023-04-14"},"publish_date":"2023-04-14","publish_status":"0","recid":"10009","relation_version_is_last":true,"title":["Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-06-19T09:47:03.094043+00:00"}